Source Precision Medicine, Inc. D/b/a Source MDx Announces 16 Molecular Diagnostic Development Programs Will Be Offered For Sale On April 29, 2011
WELLESLEY HILLS, Massachusetts, March 29, 2011 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Source Precision Medicine, Inc., d/b/a Source MDx ("Source…